Two clinical studies were implemented in 1999-2000 in China. The clinical studies conducted in China, were double-blind controlled clinical trials where NeuroAiD efficacy was assessed versus another Traditional Chinese Medicine (TCM) proven to be superior to Citicoline in separate trials.
In 2005-06, three additional safety trials were implemented on NeuroAiD™. The conclusion of these studies is that NeuroAiD™ can safely be administered without modification of hematological and bio-chemical parameters. Below is an abstract of the scientific paper written after completion of studies, this paper has undergone peer-review process and will be published in the Cerebrovascular [...]
